HOME Top Market Reports 3D Cell Culture Market by Technology (Scaffold Based, Scaffold Free), Application (Cancer Cell Research, Cell-based Assays/Toxicity Screening), End-Users (Biotechnology & Pharmaceuticals Industries) and Geography- Global Forecast to 2021

3D Cell Culture Market by Technology (Scaffold Based, Scaffold Free), Application (Cancer Cell Research, Cell-based Assays/Toxicity Screening), End-Users (Biotechnology & Pharmaceuticals Industries) and Geography- Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: July 2016
Report Code: BT 4414

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global 3D cell culture market is expected to reach USD 1345.2 Million by 2021 from USD 466.8 Million in 2016, at a CAGR of 23.6%. The global market is broadly classified by technology, application, end user, and region.

On the basis of technology, the 3D cell culture market is segmented into scaffold-based and scaffold free. The scaffold-based segment is further categorized into hydrogels/ECM analogs, solid scaffolds, micropatterned surfaces, and others. Scaffold free segment is further classified into attachment resistant surfaces and suspension cultures. Scaffold-based segment is expected to account for the largest share of the global market in 2016. Due to the variety of material and structural choices for scaffold, they are widely used in various applications in the market. Also, as they provide a surface on which the cells can grow, they can easily impart 3D growth with little alteration to cell culture procedures.

On the basis of type of application, the 3D cell culture market is segmented into cell-based assays/toxicity screening, cancer cell research, 3D printing/microfluidics, regenerative medicine, and in vivo applications for stem cell. The cancer cell research segment is expected to account for the largest share of this market. The rising incidences of cancer have created a need for conducting research to develop new treatment options. As cell culture techniques are used in the R&D and production of vaccines, drugs, therapeutics, and antibiotics, this factor can be expected to drive the market for 3D cell culture.

End users of the 3D cell culture market are research laboratories & institutes, biotechnology & pharmaceutical industries, and hospitals & diagnostic centers. The biotechnology & pharmaceutical industries segment is expected to account for the largest share of the global market in 2016. The rising incidences of cancer has created a need for advanced drugs and therapies, thus leading for the largest share of this segment.

Geographically, the 3D cell culture market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by increasing government support in the form of grants and funding, rising incidences of cancer, expanding biopharmaceutical industry, and launch of new products in the market.

The prominent players in the 3D cell culture market include 3D Biotek LLC (U.S.), Becton, Dickinson and Company (U.S.), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), Global Cell Solutions, Inc. (U.S.), Kuraray Co. Ltd. (Japan), Lonza Group (Switzerland), Merck & Co., Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Reinnervate Ltd, (a subsidiary of ReproCELL) (U.K.), and others.

Target Audience for this Report:

  • Pharmaceutical and Biopharmaceutical Companies
  • Manufacturers of Cell Culture Equipment
  • Contract Research Organizations
  • Life Science Research Institutes
  • Venture Capitalists
  • Research and Consulting Firms

Value Addition for the Buyer:

This report aims to provide insights into the global 3D cell culture market. It provides valuable information on the technologies, applications, and end users in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

The above-mentioned information would benefit the buyer by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize the growth opportunities.

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This report categorizes the 3D cell culture market into the following segments:

3D Cell Culture Market, By Technology

  • Scaffold-Based
    • Hydrogels/ECM Analogs
    • Solid Scaffolds
    • Micropatterned Surfaces
    • Others
  • Scaffold Free   
    • Attachment Resistant Surfaces
    • Suspension Cultures

3D Cell Culture Market, By Application

  • Cell-based Assays/Toxicity Screening
  • Cancer Cell Research
  • 3D Printing/Microfluidics
  • Regenerative Medicine
  • In Vivo Applications for Stem Cell

3D Cell Culture Market, By End User

  • Research Laboratories & Institutes 
  • Biotechnology & Pharmaceutical Industries
  • Hospitals & Diagnostic Centers
  • Others

3D Cell Culture Market, By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • RoE
  • Asia-Pacific
    • China
    • Japan
    • India
    • Republic of Korea
    • Australia
    • RoA
  • Rest of the World (RoW)

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunities Assessment: A detailed report underlining the various growth opportunities in the market

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency & Pricing
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Market Share Estimation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 28)
    4.1 Lucrative Opportunities in the 3D Cell Culture Market

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 Regenerative Medicines Market Segmentation, By Technology
           5.2.2 Regenerative Medicines Market Segmentation, By Application
           5.2.3 Regenerative Medicines Market Segmentation, By End User
    5.3 Market Dynamics
    5.4 Drivers
           5.4.1 Rising Investment in Research Related Activities
           5.4.2 Technological Advancements
           5.4.3 Funding for Cell Based Research
    5.5 Restraints
           5.5.1 High Cost of Cell Biology Research
           5.5.2 Lack of Infrastructure for Cell Based Research in Emergeing Countries
    5.6 Opportunities
           5.6.1 Rising Demand for Organ Transplantation
           5.6.2 Increase in R&D Spending
    5.7 Challenges
           5.7.1 Lack of Consistency in 3D Cell Culture Products

6 Global 3D Cell Culture Market, By Technology (Page No. - 40)
    6.1 Introduction
    6.2 Scaffold Based
           6.2.1 Hydrogels/Ecm Analogs
           6.2.2 Solid Scaffolds
           6.2.3 Micropatterened Surfaces
    6.3 Scaffold Free
           6.3.1 Hanging Drop Plates
           6.3.2 3-D Bioreactors
           6.3.3 Magnetic Levitations & 3D Bioprinting
           6.3.4 Microfluidics
           6.3.5 Ultra-Low Attachment Plates
           6.3.6 3-D Petrisidhes

7 Global 3D Cell Culture Market, By Application (Page No. - 50)
    7.1 Introduction
    7.2 Cancer Cell Research
    7.3 Cell Based Assays/Toxicity Screening
    7.4 Regenerative Medicine/Tissue Engineering
    7.5 In Vivo Applications for Stem Cells
    7.6 3D Printing/Microfluidics
    7.7 Others

8 Global 3D Cell Culture Market, By End User (Page No. - 58)
    8.1 Introduction
    8.2 Biotechnology and Pharmaceutical Industries
    8.3 Research Laboratories
    8.4 Hospitals and Diagnostic Centers
    8.5 Others

9 Global 3D Cell Culture Market, By Region (Page No. - 71)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 UK
           9.3.3 France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Rest of Europe (RoE)
    9.4 Asia-Pacific
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 126)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Situation and Trends
             10.3.1 New Product Launches
             10.3.2 Acquisitions
             10.3.3 Regulatory Approvals
             10.3.4 Partnerships

11 Company Profile (Page No. - 133)
(Overview, Financial*, Products & Services, Strategy, and Developments)
     11.1 Introduction
     11.2 Thermo Fisher Scientific
     11.3 BD
     11.4 Corning Incorporated
     11.5 Lonza AG
     11.6 Sigma-Aldrich Co.LLC.
     11.7 Hi Media Laboratories
     11.8 Promocell GmbH
     11.9 3D Biotek LLC.
     11.10 Bell Brook Labs.
     11.11 Kurray Co.Ltd
     11.12 Global Cell Solutions

*Details Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 153)
     12.1 Insights From Industry Experts
     12.2 Discussion Guide
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.5 Available Customizations
     12.6 Related Reports


List of Tables (66 Tables)

Table 1 Global 3D Cell Culture Market Size, By Technology, 2014–2021 (USD Billion)
Table 2 Market Size, By Technology, 2014-2021 (USD Million)
Table 3 Scaffold Based Market Size, By Technology, 2014-2021 (USD Million)
Table 4 Scaffold Based Market Size By Region
Table 5 Hydrogels/Ecm Analogs Market Size By Region, 2014-2021 (USD Million)
Table 6 Solid Scaffold Market Size, By Region
Table 7 Micropatterened Surfaces Market Size, By Region, 2014-2021 (USD Million)
Table 8 Scaffold Free Market Size, By Technology, 2014-2021 (USD Million)
Table 9 Scaffold Free Market Size, By Region, 2014-2021 (USD Million)
Table 10 Ultra-Low Attachemnet Plates Market Size, By Region, 2014-2021 (USD Million)
Table 11 3D Petri Dishes Market, By Region, 2014-2021 (USD Million)
Table 12 Microfluidics Market, By Region, 2014-2021 (USD Million)
Table 13 Hanging Drop Plates Market, By Region, 2014-2021 (USD Million)
Table 14 3-D Bioreactors Market, By Region, 2014-2021 (USD Million)
Table 15 Magnetic Levitation and 3-D Bioprinting Market, By Region, 2014-2021 (USD Million)
Table 16 Cancer Cell Culture Market, By Region, 2014-2021 (USD Million)
Table 17 Cell Based Assay/Toxicity Screening Market Size, By Region, 2014-2021 (USD Million)
Table 18 Regenrative Medicine/Tissue Engineering Market Size, By Region, 2014-2021 (USD Million)
Table 19 Others Market, By Region, 2014–2021 (USD Million)
Table 20 Market Size, By Enduser
Table 21 Market in Pharmaceutical and Biotechnology Companies, By Geography, 2014-2021 (USD Million)
Table 22 Market in Research Laboratories and Institutes, By Geography, 2014-2021 (USD Million)
Table 23 Market in Hospitals and Diagnostic Centers, By Geography, 2014-2021 (USD Million)
Table 24 North America Market, By Country, 2014-2021 (USD Million)
Table 25 North America Market, By Technology, 2014-2021 (USD Million)
Table 26 North America Market, By Application, 2014-2021 (USD Million)
Table 27 U.S. Market, By Technology, 2014-2021 (USD Million)
Table 28 U.S. Market, By Application, 2014–2021 (USD Billion)
Table 29 U.S. Regenerative Medicines Market, By End User, 2014–2021 (USD Million)
Table 30 Canada Market, By Technology, 2014-2021 (USD Million)
Table 31 Canada Cell-Based Products Market, By Enduser, 2014–2021 (USD Billion)
Table 32 Canada Market, By Application, 2014–2021 (USD Billion)
Table 33 Europe Regenerative Medicines Market, By Geography, 2014–2021 (USD Billion)
Table 34 Europe Market, By Technology, 2014-2021 (USD Million)
Table 35 Europe Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 36 Europe Market, By Application, 2014–2021 (USD Billion)
Table 37 Germany Market, By Technology, 2014-2021 (USD Million)
Table 38 Germany Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 39 Germany Market, By Application, 2014–2021 (USD Billion)
Table 40 UK Market, By Technology, 2014-2021 (USD Million)
Table 41 UK Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 42 UK Regenerative Medicines Market, By Application, 2014–2021 (USD Billion)
Table 43 France Market, By Technology, 2014-2021 (USD Million)
Table 44 France Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 45 France Market, By Application, 2014–2021 (USD Billion)
Table 46 Italy Market, By Technology, 2014-2021 (USD Million)
Table 47 Italy Cell-Based Products Market, By Enduser, 2014–2021 (USD Billion)
Table 48 Italy Market, By Application, 2014–2021 (USD Billion)
Table 49 Spain Market, By Technology, 2014-2021 (USD Million)
Table 50 Spain Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 51 Spain Market, By Application, 2014–2021 (USD Billion)
Table 52 Rest of Europe(RoE) Regenerative Medicines Market, By Technology, 2014–2021 (USD Billion)
Table 53 Rest of Europe(RoE) Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 54 Rest of Europe (RoE) Regenerative Medicines Market, By Application, 2014–2021 (USD Billion)
Table 55 Asia-Pacific Regenerative Medicines Market, By Country, 2014–2021 (USD Billion)
Table 56 Asia-Pacific Market, By Technology, 2014-2021 (USD Million)
Table 57 Asia-Pacific Market, By Application, 2014–2021 (USD Billion)
Table 58 Asia-Pacific Regenerative Medicines Market, By End User, 2013–2021 (USD Billion)
Table 59 RoW Market, By Technology, 2014-2021 (USD Million)
Table 60 RoW Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 61 RoW Market, By Application, 2014–2021 (USD Billion)
Table 62 New Product Launches, 2013–2016
Table 63 Acquisitions, 2014–2016
Table 64 Regulatory Approvals, 2013–2016
Table 65 Partnerships, 2016
Table 66 Agreements, 2013–2016


List of Figures (72 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation Methodology: Bottom-Up Approach
Figure 3 Market Size Estimation Methodology: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Global Market to Witness High Growth Rate During the Forecast Period
Figure 7 Scaffold Based Technology Dominates the Market
Figure 8 Market Segmentation
Figure 9 Market Segmentation, By Technology
Figure 10 Market Segmentation, By Application
Figure 11 Market Segmentation, By End User
Figure 12 Market Segmentation, By Region
Figure 13 Drivers, Restraints, Opportunities, and Challenges
Figure 14 Scaffold Based Technology Segment Dominated the Market
Figure 15 North America Accounted for the Largest Share of Global Market for Scaffold Based Technology Segment
Figure 16 Drivers, Restraints, Opportunities, and Challenges
Figure 17 Hydropgels/Ecm Analogs Accounted for the Largest Share of Scaffold Based Market
Figure 18 North America Accounted for the Largest Share of the Global 3D Cell Culure Marketfor Scaffold Based Technology
Figure 19 Europe is the Fastest Grwoing Regionin the Scaffold Based Market for Solid Scaffold Technology in 2015
Figure 20 Europe Dominated the Scaffold Based Market for Micropatterened Surfaces
Figure 21 Hanging Drop Plates is the Fastest Growing Segment of Scaffold Free Technology in Market
Figure 22 North America is the Fastest Growing Region in the Global Market for Scaffold Free Technology
Figure 23 Cancer Cell Research to Dominate the Market in 2015
Figure 24 North America to Command the Largest Share of Market for Cancer Cell Research in 2015
Figure 25 North America to Command the Largest Share of Market for Cell Based Research in 2015
Figure 26 North America to Command the Largest Share of Market for Regenrative Medicine in 2015
Figure 27 Market Size, By Application, 2014-2021
Figure 28 Market Size, By Enduser
Figure 29 Market in Pharmaceutical and Biotechnology Companies, By Geography, 2014-2021 (USD Million)
Figure 30 Market in Hospitals and Diagnostic Centers, By Geography, 2014-2021 (USD Million)
Figure 31 Market Segmentation, By Application
Figure 32 Orthopedic & Musculoskeletal Spine Segment Dominated the Regenerative Medicine Application Market in 2015
Figure 33 North America Accounted for the Largest Share of the Global Regenerative Medicines Market for Orthopedic & Musculoskeletal Spine in 2015
Figure 34 North America Dominated the Regenerative Medicines Market for Dermatology in 2015
Figure 35 Asia-Pacific is the Fastest Growing Region in the Global Regenerative Medicines Market for Cardiovascular Applications
Figure 36 North America Dominated the Regenerative Medicines Market for Central Nervous System Applications in 2015
Figure 37 Asia-Pacific is the Fastest Growing Region in the Global Regenerative Medicines Market for Oncology Application
Figure 38 Asia-Pacific is the Fastest Growing Region in the Global Regenerative Medicines Market for Diabetes Application
Figure 39 North America Dominated the Regenerative Medicines Market for Other Applications in 2015
Figure 40 Europe 3D Cell Culture Snapshot
Figure 41 North America Regenerative Medicines Market Snapshot
Figure 42 Cell-Based Products Segment Accounted for the Largest Share of the North America Regenerative Medicines Market in 2015
Figure 43 Orthopedic & Musculoskeletal Spine Application Segment Accounted for the Largest Share of the North America Regenerative Medicines Market in 2015
Figure 44 Cell Therapy Segment Accounted for the Largest Share of the North America Regenerative Medicines Therapy Market in 2015
Figure 45 Cell-Based Products Segment Accounted for the Largest Share of the U.S. Regenerative Medicines Market in 2015
Figure 46 Orthopedic & Musculoskeletal Spine Application Segment Accounted for the Largest Share of the U.S. Regenerative Medicines Market in 2015
Figure 47 Cell Therapy Segment Accounted for the Largest Share of the U.S. Regenerative Medicines Therapy Market
Figure 48 Cell-Based Products Segment Accounted for the Largest Share of the Canada Regenerative Medicines Market in 2015
Figure 49 3D Cell Culture Market Size
Figure 50 3D Cell Culture Market to Grow at the Highest Rate (2016-2021)
Figure 51 North America 3D Culture Market Snapshot
Figure 52 U.S to Dominate the North American 3D Cell Culture Market in 2015
Figure 53 Among Applications, the Cancer Research Segment Accounted for the Largest Share in the Europe 3D Cell Culture Market in 2015
Figure 54 Germany Dominated the European 3D Cell Culture Market in 2015
Figure 55 Cancer Research Accounted for the Largest Share of the U.K. 3D Cell Culture Market in 2015
Figure 56 Asia-Pacific 3D Cell Culture Market Snapshot
Figure 57 Among Technology, Scaffold Based Segment Accounted for the Largest Share in the Asia-Pacific 3D Cell Culture Market in 2015
Figure 58 Among Applications, the Cancer Research Segment Accounted for the Largest Share in the Asia-Pacific 3D Cell Culture Market in 2015
Figure 59 Among End User Pharma and Biotechnology Companies Segment Accounted for the Largest Share in the Asia-Pacific 3D Cell Culture Market
Figure 60 The Scaffold Based Segment Accounted for the Largest Share in the RoW 3D Cell Culture Market in 2015
Figure 61 Among Applications, the Pharma and Biotechnology Companies Segment Accounted for the Largest Share in the RoW 3D Cell Culture Market in 2015
Figure 62 Leading Market Players Adopted Both Organic and Inorganic Growth Strategies Over the Last Four Years (2013–2016)
Figure 63 Global 3D Cell Culture Market Share Analysis, By Key Player, 2015
Figure 64 Battle for Market Share: New Product Launches & Product Enhancements is the Key Strategy
Figure 65 Geographic Revenue Snapshot (2015)
Figure 66 Thermo Fisher Scientific: Company Snapshot
Figure 67 BD: Company Snapshot
Figure 68 Corning Incorporated: Company Snapshot
Figure 69 Lonza AG: Company Snapshot
Figure 70 Sigma-Aldrich Co.LLC: Company Snapshot
Figure 71 Promocell GmbH.: Company Snapshot
Figure 72 3D Biotek LLC: Company Snapshot

The global 3D cell culture market size is expected to reach USD 1345.2 Million by 2021, at a CAGR of 23.6% during the forecast period of 2016 to 2021.

The report on global 3D cell culture market analyzes and segments the market on the basis of technology, product, application, and region. It analyzes the competitive developments, such as alliances, joint ventures, and mergers & acquisitions in the global market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments.

In 3D cell culture, the cells are grown in all directions in a 3D environment forming 3D spheroids or 3D cell colonies. It forms 3D bioreactors, 3D scaffolds, multiwells, hydrogels, and others. Growing cells in this environment have many advantages such as more drug penetration and give better resemblance to tumor microenvironment. It also brings more changes in gene expression and cell behavior, especially in cancer research.

The driving forces for global 3D cell culture market include increasing use of 3D cell cultures in cancer research and drug discovery. Along with this, increasing investments by pharmaceutical companies, government initiatives, rapid increase in the organ transplantation, and increasing use of microfluidic technology are also fueling the market growth. The restraints for this market are the lack of experienced professionals, lack of consistency in 3D cell culture products, budget restraints by laboratories, and ethical concerns regarding using animal sources.

By technology, scaffolds-based segment dominates the market in 2015. By application, the segments are cancer cell research, cell based assays/toxicity screening, regenerative medicine/tissue engineering, in vivo applications for stem cells, and 3D printing/microfluidics. The cancer cell research application segment dominated the market in 2015 because of increasing investments and rise in research on tumor cells in 3D environment.

By end user, the biotechnology & pharmaceutical industries segment leads the market of 3D cell culture as they are increasing their research programs in this area. Other end  users are research laboratories & institutes, hospitals & diagnostics centres, and others.

The global 3D cell culture market was dominated by North America in 2015, followed by Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to continue to lead the market in coming years, followed by Europe. The market in Asia-Pacific is expected to have the highest CAGR during the forecast period 2016 to 2021. The growth in this region is expected to be driven by rising number of research in 3D cell culture especially in Japan, increasing per capita healthcare expenditure, and increasing government initiatives.

3D Cell Culture Market

Some of the key players of the global 3D Cell Culture market are 3D Biotek LLC (U.S.), Becton, Dickinson and Company  (U.S.), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), Global Cell Solutions, Inc. (U.S.), Kuraray Co. Ltd. (Japan), Lonza Group (Switzerland), Merck & Co., Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Reinnervate Ltd. (a subsidiary of ReproCELL) (U.K.), and others.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo